Compare NATL & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATL | LMAT |
|---|---|---|
| Founded | 2023 | 1983 |
| Country | United States | United States |
| Employees | 20000 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.1B |
| IPO Year | 2023 | 2006 |
| Metric | NATL | LMAT |
|---|---|---|
| Price | $46.26 | $81.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $45.60 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 558.7K | 223.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 73.98 | 30.57 |
| EPS | 1.15 | ★ 1.42 |
| Revenue | ★ $4,354,000,000.00 | $249,602,000.00 |
| Revenue This Year | $6.13 | $14.21 |
| Revenue Next Year | $4.24 | $8.88 |
| P/E Ratio | ★ $40.07 | $55.77 |
| Revenue Growth | 0.86 | ★ 13.53 |
| 52 Week Low | $33.31 | $78.22 |
| 52 Week High | $48.50 | $118.01 |
| Indicator | NATL | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.17 |
| Support Level | N/A | $78.65 |
| Resistance Level | N/A | $82.45 |
| Average True Range (ATR) | 0.00 | 1.68 |
| MACD | 0.00 | 0.45 |
| Stochastic Oscillator | 0.00 | 37.42 |
NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.